0

BEYAZ از شرکت BAYER HLTHCARE

تصویر پیدا نشد !

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

BEYAZ از شرکت BAYER HLTHCARE

New Drug Application (NDA): 022532

Company: BAYER HLTHCARE

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
BEYAZ DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM 3MG,N/A;0.02MG,N/A;0.451MG,0.451MG TABLET;ORAL Prescription

AB

Yes Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
09/24/2010 ORIG-1 Approval

Type 4 – New Combination

STANDARD

Label (PDF)

Letter (PDF)

Review

Summary Review (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022532s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/022532s000ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022532_beyaz_toc.cfm
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022532Orig1s000SumR.pdf

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
08/09/2017 SUPPL-9 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022532s009lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/022532Orig1s009ltr.pdf

05/11/2016 SUPPL-7 Manufacturing (CMC)

Label is not available on this site.

06/01/2015 SUPPL-6 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022532s006lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/021098Orig1s023,022532Orig1s006,022574Orig1s006,021676Orig1s014ltr.pdf

04/10/2012 SUPPL-4 Labeling-Package Insert

Label (PDF)

Letter (PDF)

Review (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022532s004lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021098s022,021676s012,022532s004,022574s004ltr.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/022532Orig1s004.pdf

02/13/2012 SUPPL-1 Efficacy-Labeling Change With Clinical Data

Label (PDF)

Letter (PDF)

Review (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022532s001lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/022532s001ltr.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/022532Orig1s001.pdf

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
08/09/2017 SUPPL-9

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022532s009lbl.pdf
06/01/2015 SUPPL-6

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022532s006lbl.pdf
04/10/2012 SUPPL-4

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022532s004lbl.pdf
02/13/2012 SUPPL-1

Efficacy-Labeling Change With Clinical Data

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022532s001lbl.pdf
09/24/2010 ORIG-1 Approval

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022532s000lbl.pdf

BEYAZ

TABLET;ORAL; 3MG,N/A;0.02MG,N/A;0.451MG,0.451MG

TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
BEYAZ DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM 3MG,N/A;0.02MG,N/A;0.451MG,0.451MG TABLET;ORAL Prescription Yes AB 022532 BAYER HLTHCARE
DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM 3MG,N/A;0.02MG,N/A;0.451MG,0.451MG TABLET;ORAL Prescription No AB 205947 LUPIN LTD
DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM 3MG,N/A;0.02MG,N/A;0.451MG,0.451MG TABLET;ORAL Prescription No AB 203593 WATSON LABS INC
حتما بخوانید : BEXAROTENE از شرکت BIONPHARMA INC
برچسب‌ها:

نظرات کاربران